Video

Expert: MDMA-Assisted Therapy Has Potential Benefits for Women with Hypoactive Sexual Desire Disorder

Kelsey Ramsden, CEO of Mind Cure Health, said research into the use of MDMA-assisted therapy could have a huge impact on the treatment of female hypoactive sexual desire disorder.

In part 1 of an interview with Pharmacy Times, Kelsey Ramsden, CEO of Mind Cure Health, said research into the use of MDMA-assisted therapy could have a huge impact on the treatment of female hypoactive sexual desire disorder.

Mind Cure Health has launched The Desire Project, which is investigating the potential use of MDMA-assisted psychotherapy for the treatment of female hypoactive sexual desire disorder. In the interview, Ramsden discussed how sexual health is directly linked with mental health, how MDMA-assisted psychotherapy could be used to treat the disorder, and why the Desire Project is directly focusing on women.

Related Videos
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards
October is American Pharmacists Month.
smiling indian male doctor or pharmacist in white coat with stethoscope and clipboard over drugstore background
Efficient healthcare supply chain management ensures timely delivery of medical supplies and medications